In Brief
This article was originally published in The Tan Sheet
Executive Summary
FDA clarifies pre-emption on OTC labeling
You may also be interested in...
J&J Directors Find Root Causes But Little Blame For OTC Quality Issues
A report by a Johnson & Johnson special committee finds organizational and middle management changes at the firm were the root causes of manufacturing and quality control lapses in the OTC drug business.
Merck's Frazier Promoted To CEO To Drive Post-Schering Success
Merck & Co. announced Nov. 30 it promoted current president Kenneth Frazier to CEO effective Jan. 1.
On Pre-emption, OTC Rule Among Signs Tipping Obama Administration’s Hand
FDA has not altered its support of pre-emption in product liability suits but there are signs it will happen under the Obama administration